HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Luz Ibarra-Lara Selected Research

Clofibrate

1/2019Clofibrate Treatment Decreases Inflammation and Reverses Myocardial Infarction-Induced Remodelation in a Rodent Experimental Model.
8/2016Peroxisome proliferator-activated receptor-α stimulation by clofibrate favors an antioxidant and vasodilator environment in a stressed left ventricle.
5/2015PPARα Stimulation Modulates Myocardial Ischemia-induced Activation of Renin-Angiotensin System.
10/2012Clofibrate PPARα activation reduces oxidative stress and improves ultrastructure and ventricular hemodynamics in no-flow myocardial ischemia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Luz Ibarra-Lara Research Topics

Disease

4Myocardial Ischemia (Ischemic Heart Diseases)
01/2020 - 10/2012
4Myocardial Infarction
01/2020 - 12/2016
3Ischemia
01/2020 - 05/2015
3Aortic Coarctation
01/2019 - 02/2010
3Hypertension (High Blood Pressure)
01/2019 - 02/2010
2Metabolic Syndrome (Dysmetabolic Syndrome X)
01/2020 - 12/2016
2Inflammation (Inflammations)
01/2019 - 10/2012
1Hypoxia (Hypoxemia)
01/2021
1Ventricular Remodeling
01/2019
1Cardiovascular Diseases (Cardiovascular Disease)
12/2016
1Insulin Resistance
12/2016

Drug/Important Bio-Agent (IBA)

7salicylhydroxamic acid (SHAM)IBA
01/2020 - 10/2012
4Angiotensin IIIBA
01/2020 - 02/2010
4ClofibrateFDA Link
01/2019 - 10/2012
3Fenofibrate (CiL)FDA LinkGeneric
01/2021 - 12/2016
3Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA
01/2020 - 05/2015
3PPAR alphaIBA
01/2020 - 02/2010
3AntioxidantsIBA
12/2016 - 02/2010
2angiotensin I (1-7)IBA
01/2020 - 01/2019
2Peroxisome Proliferator-Activated Receptors (PPAR)IBA
08/2016 - 10/2012
1Reactive Oxygen Species (Oxygen Radicals)IBA
01/2021
1Glucose (Dextrose)FDA LinkGeneric
01/2021
1Neprilysin (Neutral Endopeptidase)IBA
01/2020
1Angiotensin IIIIBA
01/2020
1des-Asp(1)-des-Arg(2)-Ile(5)- angiotensin IIIBA
01/2020
1Angiotensin Receptors (Angiotensin II Receptor)IBA
01/2020
1Creatine Kinase (Creatine Phosphokinase)IBA
01/2020
1Insulin (Novolin)FDA Link
12/2016
1Fibric Acids (Fibrates)IBA
12/2016
1HDL CholesterolIBA
12/2016
1Triglycerides (Triacylglycerol)IBA
12/2016
1Vasodilator Agents (Vasodilators)IBA
12/2016
1Type 1 Angiotensin ReceptorIBA
12/2016
1Captopril (Capoten)FDA LinkGeneric
08/2016

Therapy/Procedure

1Therapeutics
12/2016